Irindalone (INN; developmental code name LU-21098 or Lu 21-098) is a predominantly peripherally acting, highly potent, and selective serotonin 5-HT2 receptor antagonist which was under development for the treatment of hypertension but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.